» Articles » PMID: 38552795

Stuck in Pandemic Uncertainty: a Review of the Persistent Effects of COVID-19 Infection in Immune-deficient People

Overview
Publisher Elsevier
Date 2024 Mar 29
PMID 38552795
Authors
Affiliations
Soon will be listed here.
Abstract

Background: People who are immune-deficient/disordered (IDP) are underrepresented in COVID-19 studies. Specifically, there is limited research on post-SARS-CoV-2 infection outcomes, including viral persistence and long-term sequelae in these populations.

Objectives: This review aimed to examine the published literature on the occurrence of persistent SARS-CoV-2 positivity, relapse, reinfections, variant coinfection, and post-acute sequelae of COVID-19 in IDP. Although the available literature largely centred on those with secondary immunodeficiencies, studies on people with inborn errors of immunity are also included.

Sources: PubMed was searched using medical subject headings terms to identify relevant articles from the last 4 years. Articles on primary and secondary immunodeficiencies were chosen, and a special emphasis was placed on including articles that studied people with inborn errors of immunity. The absence of extensive cohort studies including these individuals has limited most articles in this review to case reports, whereas the articles focusing on secondary immunodeficiencies include larger cohort, case-control, and cross-sectional studies. Articles focusing solely on HIV/AIDS were excluded.

Content: Scientific literature suggests that IDP of any age are more likely to experience persistent SARS-CoV-2 infections. Although adult IDP exhibits a higher rate of post-acute sequelae of COVID-19, milder COVID-19 infections in children may reduce their risk of experiencing post-acute sequelae of COVID-19. Reinfections and coinfections may occur at a slightly higher rate in IDP than in the general population.

Implications: Although IDP experience increased viral persistence and inter-host evolution, it is unlikely that enough evidence can be generated at the population-level to support or refute the hypothesis that infections in IDP are significantly more likely to result in variants of concern than infections in the general population. Additional research on the relationship between viral persistence and the rate of long-term sequelae in IDP could inform the understanding of the immune response to SARS-CoV-2 in IDP and the general population.

References
1.
Antinori A, Bausch-Jurken M . The Burden of COVID-19 in the Immunocompromised Patient: Implications for Vaccination and Needs for the Future. J Infect Dis. 2023; 228(Suppl 1):S4-S12. PMC: 10401620. DOI: 10.1093/infdis/jiad181. View

2.
Bradley R, Ponsford M, Scurr M, Godkin A, Jolles S . Persistent COVID-19 Infection in Wiskott-Aldrich Syndrome Cleared Following Therapeutic Vaccination: a Case Report. J Clin Immunol. 2021; 42(1):32-35. PMC: 8554737. DOI: 10.1007/s10875-021-01158-5. View

3.
Harari S, Tahor M, Rutsinsky N, Meijer S, Miller D, Henig O . Drivers of adaptive evolution during chronic SARS-CoV-2 infections. Nat Med. 2022; 28(7):1501-1508. PMC: 9307477. DOI: 10.1038/s41591-022-01882-4. View

4.
Sciscent B, Eisele C, Ho L, King S, Jain R, Golamari R . COVID-19 reinfection: the role of natural immunity, vaccines, and variants. J Community Hosp Intern Med Perspect. 2021; 11(6):733-739. PMC: 8604456. DOI: 10.1080/20009666.2021.1974665. View

5.
Machkovech H, Hahn A, Garonzik Wang J, Grubaugh N, Halfmann P, Johnson M . Persistent SARS-CoV-2 infection: significance and implications. Lancet Infect Dis. 2024; 24(7):e453-e462. DOI: 10.1016/S1473-3099(23)00815-0. View